ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.10 Cr | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.10 Cr |
| Mar2024 | - |
| Mar2023 | ₹3.23 Cr |
| Mar2022 | ₹3.23 Cr |
| Mar2021 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.10 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹3.23 Cr | 0.00 | |
| Mar2022 | ₹3.23 Cr | 0.00 | |
| Mar2021 | ₹3.23 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,065.7 Cr | 1.1% | 2.7% | 38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 1.1% |
2.7% |
38.7% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses